Issues in the Management of Hemophilia: A Best Practice Series

Slides:

Advertisements

Similar presentations

Type 1 Diabetes: Meters, Pumps, and Transitions to Adulthood

Advertisements

Statin Selection in the Elderly

Chronic Hepatitis C Virus Infection

Managing Women Living With HIV Infection

NOACs In Long-term VTE Treatment: A State Of The Art Review

MR Imaging in Children.

Advances in Managing Inhibitors in Patients With Hemophilia A

Prophylaxis Considerations for Teenagers and Young Adults With Severe Hemophilia.

Tailoring Statin Therapy in Women

Heart Rate, HF Admissions, and Readmissions

NOACs in Clinical Practice: Are They All the Same?

COPD Management.

Introduction Antiplatelet Agents ADP Receptor Antagonists.

Select Topics in Cardiovascular Medicine

Hemophilia Updates: Incorporating New Concepts Into Practice

Extended Half-life Factor Products in the Management of Hemophilia

Clinical Advances in Type 2 Diabetes and Cardiovascular Risk

Individualizing Prophylaxis in Hemophilia

Hot Topics in Hemophilia Nursing

Mid-Year Hemophilia Update

Issues in the Management of Hemophilia: A Best Practice Series

Transition of Care in Epilepsy Among Patients Entering Long-Term Care

Emerging Data in Cancer Supportive Care

ACIP Recommended Vaccines for Adults – By Age

IL-17 Inhibitors in the Management of Psoriatic Disease

Tailoring Hemophilia Prophylaxis Therapy

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

Activity Goals. Activity Goals Case Presentation.

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Addressing Challenges in Factor VIII Inhibitors in Children With Hemophilia.

Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.

Learning Objectives Current Practices in Ruling Out AMI.

Individualizing Factor Replacement Therapy for Patients With Hemophilia.

Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA

EHL Technologies in Hemophilia Care

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

Personalized Therapy in Relapsed or Refractory CLL

Multidisciplinary Approaches to Managing Hemophilia

What Does It Take to Be a Long-Acting Replacement Therapy in Hemophilia A?

US and European Perspectives on Sinusoidal Obstruction Syndrome

CMV in the HSCT Recipient

Prolonging the Effects of Factor IX Replacement Therapy in Hemophilia B.

Battling the Flu: Latest Advances in the Influenza Treatment Arsenal

Cancer-Associated Thrombosis

IgG-Fc Fusion Proteins and Immunomodulation: What Does the Science Tell Us?

Managing Age-Related Clinical Issues in Hemophilia

Extended Half-life Factor Products in the Management of Hemophilia

Program Goals Disclaimers Defining Refractory Seizures.

Updates From the 2015 Meetings in Hemophilia

Current Challenges in Managing Hemophilia

The Changing Field of Melanoma: Ipilimumab.

Optimizing Joint Health in Hemophilia

Add-On Therapy to Insulin in T1DM Management

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

Etiology and Incidence Pathophysiology Hemophilia is due to a defect in thrombin generation on the platelet surface.

Healthy With HIV.

Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA

Improving Adherence to Antiplatelet Therapy After an ACS Event

Assessing the Burden of Hyperkalemia

Selecting Treatment Approaches in Hemophilia

Assessing the Burden of Hyperkalemia

Would Patients With Hemophilia B Benefit From Switching to Extended Half-Life Factor Products?

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Balancing the Risks and Benefits of Multidrug Regimens in the Clinical Management of Nontuberculous Mycobacterial Lung Disease.

Expert Insights in Diagnosis and Management of Common Drug-Induced Movement Disorders.

Examining the Role of Pharmacokinetics in Hemophilia

Risk Stratification in MDS

Foundations of Asthma.

Navigating the Journey

Fresh perspectives ON BASAL Insulins in diabetes care

Presentation transcript:

Issues in the Management of Hemophilia: A Best Practice Series

Managing Hemophilia in Adults

Introduction

Scenario 1: Young Man in Transition

Young Adults With Hemophilia

Considerations for Tailoring Prophylaxis

Prophylaxis

Overview of EHL Factor Concentrates Available in the United States

Scenario 1 (cont)

Incorporating Technological Tools

Scenario 2: Older PWH

Managing Hemophilia in Older PWH

Weighing Regimens for Older PWH

Burden of Age in Hemophilia

Novel Subcutaneous Agents

Surgery and Inhibitors in Older PWH

High-Titer Inhibitors in PWH

Scenario 3: Cardiovascular Risk in PWH

CVD Risk Factors in PWH

Prevalence of Hypertension in PWH

Managing Hypertension in PWH

Challenges of Managing CVD in PWH

Prophylaxis and Antithrombotic Agents

Coordinating Specialist Care

Summary

Abbreviations

Abbreviations (cont)